Time Interval as a Quality Measure: What Is Our Baseline Prior to Nurse Navigator Implementation?

September 2011 Vol 2, No 5

Categories:

Tracking Processes
Miral Amin, MD
Mohua Basu
Sharla Gayle Patterson, MD
Heather Pinkerton, RN, BSN, OCN
Winship Cancer Institute of Emory University, Atlanta, Georgia
Mylin Ann Torres, MD
Mary Newell, MD
Ruth O'Regan, MD
Christine McCarthy, MS, APRN-BC
Robin Tarpley, RN, BHS
Sheryl G. A. Gabram, MD, MBA

Background: There are various outcome measures to evaluate the quality of multidisciplinary care for breast cancer patients. The National Consortium of Breast Centers defines “quality” of breast cancer care as “accurate evaluation and appropriate services in a timely manner.”

Objectives: In a tertiary academic center, a diverse referral pattern possibly influences time to treatment. We choose to examine 2 outcome mea sures before the start of a nurse navigator: Time from initial diagnosis to first consultation and if the pretreatment consultation for those receiving neoadjuvant chemotherapy or hormonal therapy included all subspecialists.

Methods: Electronic medical records of female patients with breast cancer seen during January through June 2010 were reviewed. Patients with stage IV breast cancer were excluded.

Results: In total, 150 patients were divided into 4 categories: external pathology consult (B1), internally diagnosed with a primary care physician (PCP) at our institution (B2), evaluated by a surgical oncologist before the biopsy (B3), and internally diagnosed with PCP outside of the institution (B4). For B2, B3, and B4, we examined the time intervals to first surgical oncology appointment after diagnosis as shown in the Table. For all patients (n = 10) who received neoadjuvant therapy, 1 patient saw a surgical oncologist, medical oncologist, and radiation oncologist; 9 patients saw 2 subspecialties prior to initiation of first treatment.

Conclusions: Patients are seen within an average of 2 weeks whether they are diagnosed internally (B2, B3) or externally (B4). The group seen by a surgical oncologist prior to biopsy (B3) was seen sooner. For the patients receiving neoadjuvant therapy, 10% saw all 3 specialties prior to initiation of therapy. In July 2010, a nurse navigator was added to the care team. With this new position, our goal is to decrease the time from biopsy to visit by 33% and have 100% of patients receiving neoadjuvant therapy evaluated by all 3 specialists prior to treatment. In addition, in January 2011, we implemented an e-mail–based patient satisfaction survey that is sent to all patients with whom the nurse navigator interacts. One of the questions on the survey asks for patients to rate timeliness of their care and ability to obtain appointments as soon as they wanted. Results from the first 3 months of 2011 show that patients rate their satisfaction in these 2 areas as either “satisfied” or “extremely satisfied.” Our intent is to quantify the effect of a nurse navigator in a large academic center as a quality metric in improving care.

Related Articles
The Use of Patient and Provider Satisfaction as a Metric for the Effectiveness of the Oncology Nurse Navigator in an Academic Setting
Joan Giblin, MSN, FNP-BC, AOCN, Heather Pinkerton, RN, BSN, OCN, Nancy McCormick, BSN, Bonnie Josaphs, BSN, OCN, Hayley Kenslea, MHA
|
August 2012 Vol 3, No 4
The role of the oncology nurse navigator (ONN) is expanding as the healthcare delivery system continues to change as it reacts to advances in cancer treatment and delivery, economic constraints, and increasing fragmentation that makes it difficult for consumers to navigate the healthcare system on their own.
A Path to Improving the Continuum of Care: Developing a Survivorship Program
A. Vance, RN, C. Copertino, RN, MS, OCN, S. O'Connor, RN, MSN, OCN, M. Willingham, CRNP
|
November 2011 Vol 2, No 6
The path to a survivorship program includes key elements to ensure a successful and sustainable program. At Anne Arundel Medical Center (AAMC) we implemented these fundamentals in the development of our breast survivorship program.
Nurse Navigation for Surveillance of Nodules Found on Nonscreening Imaging
Gean Brown, RN, OCN, Lisa Cull, RN, MSN, Robert Wolek, MD
|
September 2011 Vol 2, No 5
Last modified: August 10, 2023

Subscribe Today!

To sign up for our print publication or e-newsletter, please enter your contact information below.

I'd like to receive:

  • First Name *
    Last Name *
     
     
    Profession or Role
    Primary Specialty or Disease State
    Country